BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1599 related articles for article (PubMed ID: 11033584)

  • 1. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
    O'Leary BA; Olynyk JK; Neville AM; Platell CF
    J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
    Vijan S; Hwang EW; Hofer TP; Hayward RA
    Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.
    Knudsen AB; Lansdorp-Vogelaar I; Rutter CM; Savarino JE; van Ballegooijen M; Kuntz KM; Zauber AG
    J Natl Cancer Inst; 2010 Aug; 102(16):1238-52. PubMed ID: 20664028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.
    Wu GH; Wang YM; Yen AM; Wong JM; Lai HC; Warwick J; Chen TH
    BMC Cancer; 2006 May; 6():136. PubMed ID: 16723013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
    Ladabaum U; Chopra CL; Huang G; Scheiman JM; Chernew ME; Fendrick AM
    Ann Intern Med; 2001 Nov; 135(9):769-81. PubMed ID: 11694102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
    Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Habbema JD; Kuipers EJ
    J Natl Cancer Inst; 2009 Oct; 101(20):1412-22. PubMed ID: 19779203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a single colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F
    Arch Intern Med; 2002 Jan; 162(2):163-8. PubMed ID: 11802749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
    Olynyk JK; Platell CF; Collett JA
    J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening in Italy: feasibility and cost-effectiveness in a model area.
    Sorrentino D; Paduano R; Bernardis V; Piccolo A; Bartoli E
    Eur J Gastroenterol Hepatol; 1999 Jun; 11(6):655-60. PubMed ID: 10418938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of screening for colorectal cancer.
    Telford JJ; Levy AR; Sambrook JC; Zou D; Enns RA
    CMAJ; 2010 Sep; 182(12):1307-13. PubMed ID: 20624866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.